Anzeige
Mehr »
Login
Freitag, 17.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
Letzte Chance, bevor die Bohrer dieses "Monster"-Vorkommen bei einem 13-Millionen-Unternehmen ansteuern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
346 Leser
Artikel bewerten:
(1)

Entertainment Arts Research, Inc.: EARI Beverage Group Acquires Perfectomundo Tequila

Finanznachrichten News

CHARLOTTE, N.C., Feb. 22, 2023 /PRNewswire/ -- Entertainment Arts Research (OTC: EARI), a diversified beverage and media group, has concluded the acquisition of Perfectomundo, Inc., the producer, and the owner of the premium multiple award-winning tequila brand Perfectomundo Tequila.

The acquisition of Perfectomundo adds to the EARI Beverage portfolio a world-renowned multi-award-winning Tequila, which won top awards at some of the largest international shows and competitions: Wine and Spirits Wholesalers of America (WSWA); World Spirits Awards (SIP Consumer Awards), Las Vegas International Spirits Competition, San Francisco World Spirits Competition, London Bartender and Mixologist Choice Competition, as well as best-in-show and double gold in the most prestigious Stuttgart Spirits & Wine Competition.

Perfectomundo Tequila is crafted in the Town of Tequila, State of Jalisco, at one of the oldest and the most prominent distilleries in Mexico, which grows its own Agave plants. The distillery has a long legacy of producing the top shelf 100% Agave award-winning tequilas. Perfectomundo Tequila comes in three expressions - Blanco, Reposado, and Anejo. The full control over the production cycle, starting from the growth of the Agave plants to the unique distilling processes, creates a rich flavor palate appreciated by the most discerning tequila connoisseurs around the world.

Paul Oakenfold, Perfectomundo co-founder, three-time Grammy-nominee, legendary musician, and the owner of Perfecto Records, stated: "We are excited to bring this passion project, already revered by the music and entertainment industry and fans around the world, to a nationwide distribution network through EARI".

"The acquisition of Perfectomundo is a major milestone for our company as it rounds up our spirit portfolio, adding to our Vodka and Bourbon brands. It also reinforces our commitment to creating a sustainable platform that can serve our current and future customers and their unique needs," stated Bernard Rubin, the CEO of EARI Beverage Group.

ABOUT EARI:

EARI Beverages is a diversified conglomerate of beverage brands with owned media and marketing assets, focused on specific market segments of the beverage industry, operating in the craft beer, craft soda, and craft spirit market segments. The flagship brand is the iconic Original New York Seltzer craft soda, which is bottled by its wholly-owned bottling facility, LA Bottleworks Inc. The group has acquired and built distribution across 170 independent distributors and has a footprint in 10,000 retailers. The company bottles its own products and uses several third-party packers and service providers. The most recent acquisition of LA Bottleworks Inc. has provided the company with the capability to produce its own products, such as the Original New York Seltzer brand. The company also owns a craft brewer, Bell City Brewing in Canada. For more information on Perfectomundo, please visit https://perfectomundotequila.com/ and click here for the corporate video.

We also encourage our shareholders to visit www.earigroup.com and our official Twitter account for updates: https://twitter.com/EARI_Bev_Group

Company Websites

www.earigroup.com www.drinkfury.com www.whiterhinovodka.com www.neosuperwater.com www.foodytv.com http://zegen.com.ph/ https://bellcitybrewing.com/ https://laketahoedistilling.com/ https://4elementalspirits.com/

Safe Harbor Disclosure

This press release contains forward-looking statements that are made under the safe harbor provisions within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are any statement reflecting management's expectations regarding future results of operations, economic performance, and financial condition. The forward-looking statements are based on the assumption that operating performance and results will continue in line with historical results. Management believes these assumptions to be reasonable, but there is no assurance they will prove to be accurate. Forward-looking statements, specifically those concerning future performance, are subject to certain risks and uncertainties, and actual results may differ materially. EARI competes in a rapidly growing and transforming industry, and risk factors, including those disclosed in the Company's filings with the Securities and Exchange Commission, might affect the Company's operations. Unless required by applicable law, the Company undertakes no obligation to update or revise any forward-looking statements.

Cision View original content:https://www.prnewswire.co.uk/news-releases/eari-beverage-group-acquires-perfectomundo-tequila-301753572.html

© 2023 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.